LAKE FOREST, Calif.-- I-Flow Corporation announced today the launch of the new ON-Q Elite Pain Relief System, an extension of its market leading ON-Q Post-Operative Pain Relief product line.
"ON-Q Elite was specifically designed to meet the need for a simple, reusable pump that provides post-operative pain relief for surgeries performed in outpatient surgery centers," says Donald M. Earhart, I-Flow's chairman, president and CEO. "ON-Q Elite can utilize existing reimbursement codes where pain management is a covered benefit requiring the use of durable medical equipment. This cost-effective and easy to use infusion pump incorporates our patented technologies to deliver non-narcotic medication to patients in a previously underserved and growing market. ON-Q Elite will be marketed through our InfuSystem operating unit, where we expect to benefit from InfuSystem's provider contracts covering more than 120 million potential patients and use its medical insurance billing expertise to maximize the product's reimbursement opportunities. The InfuSystem business model allows us to provide a unique offering designed specifically for outpatient surgery centers."
"By including ON-Q Elite in their new standard of care, surgeons will enable patients to get back to their normal lives faster," Earhart continued. "Clearly, the introduction of ON-Q Elite strengthens our position as the emerging standard of care for post-surgical pain treatment.
The ON-Q Elite Pain Relief System is designed to infuse a local anesthetic directly to a surgical site over multiple days following a variety of surgeries, including orthopedic procedures and hernia repair.
I-Flow Corporation designs, develops and markets technically advanced drug-delivery systems that are redefining the standard of care by providing life enhancing, cost effective solutions for pain management and infusion therapy.
Source: I-Flow Corporation
The Latest on CLABSIs and CAUTIs: Evidence-Based Approaches for Infection Prevention
February 27th 2025Health care–associated infections like CLABSIs and CAUTIs threaten patient safety. Learn evidence-based strategies, new technologies, and prevention protocols to reduce these infections and improve outcomes.
Hiding in Plain Sight: The Most Harmful and Costly Hospital-Acquired Infection
February 5th 2025Nonventilator hospital-acquired pneumonia (NV-HAP) is a deadly, overlooked infection impacting patient outcomes. With new diagnostic tools and prevention strategies, hospitals must prioritize oral hygiene to reduce risk.